Asimov
Developer of mammalian cell engineering software designed to accelerate the design and manufacture of biologics and gene
Other Healthcare Technology Systems
📍 Boston, MA
Founded 2017
Current Valuation
$1.2B
as of 2023-Q1
UNICORN
Developer of mammalian cell engineering software designed to accelerate the design and manufacture of biologics and gene therapies.
Company Profile
Last Round
Series B — $175M (Jan 2023)
Fundraising Status
Series B · $175M · 3y 5mo ago
privateTotal raised $205M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $175M | Jan 2023 | — | $1.2B |
SoftwareArtificial IntelligenceBiotechnologyTherapeutics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2023-Q1. Refreshed quarterly.